Hangzhou Alltest Biotech Co., Ltd. (688606.SS)
CNY 65.98
(-1.68%)
CNY 65.98
(-1.68%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 23.91 Million CNY | 9.86% |
| 2022 | 21.76 Million CNY | -41.74% |
| 2021 | 37.36 Million CNY | 743.95% |
| 2020 | 4.42 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 3.94 Million CNY | -56.01% |
| 2024 Q1 | 21.62 Million CNY | -9.56% |
| 2024 Q2 | 10.31 Million CNY | -52.32% |
| 2023 Q3 | 26.22 Million CNY | -19.09% |
| 2023 FY | 23.91 Million CNY | 9.86% |
| 2023 Q4 | 23.91 Million CNY | -8.83% |
| 2023 Q2 | 32.41 Million CNY | -1.41% |
| 2023 Q1 | 32.88 Million CNY | 51.06% |
| 2022 FY | 21.76 Million CNY | -41.74% |
| 2022 Q3 | 36.96 Million CNY | -16.6% |
| 2022 Q4 | 21.76 Million CNY | -41.11% |
| 2022 Q2 | 44.31 Million CNY | -8.12% |
| 2022 Q1 | 48.23 Million CNY | 29.1% |
| 2021 Q2 | 4.94 Million CNY | 0.0% |
| 2021 FY | 37.36 Million CNY | 743.95% |
| 2021 Q1 | - CNY | 0.0% |
| 2021 Q4 | 37.36 Million CNY | 17.0% |
| 2021 Q3 | 31.93 Million CNY | 545.9% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 FY | 4.42 Million CNY | 0.0% |
| 2020 Q4 | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |